Qiagen is a top provider of genomic testing technology and a leader in molecular diagnostics and related instruments.


Updates from The Motley Fool

Latest updates on Qiagen from Fool.com.  The Fool has written over 100 articles on Qiagen.
1,750 Reasons to Like Qiagen NV

The lab test maker's QIAsymphony platform is driving sales of disposables that run on the machine.

Qiagen NV Is Prepping for Growth

With the decline in HPV test sales mostly behind it, the lab-test maker is looking for a stronger...



Stock Performance

View Interactive QGEN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Qiagen.
Current Price: $31.70
Prev Close: $31.52
Open: $31.70
Bid: $28.53
Ask: $34.00
Day's Range: $31.55 - $31.88
52wk Range: $24.86 - $35.26
Volume: 894,036
Avg Vol 709,822
Market Cap: $7B
P/E (ttm): 92.71
EPS (ttm): $0.34
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Qiagen.
CAPS Rating 4 out of 5
 
202 Outperform
11 Underperform
CAPS All Stars
 
50 Outperform
1 Underperform

How do you think Qiagen will perform against the market?



You pick for Qiagen is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Peer M. Schatz, CEO

57% Approve

Based on 115 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Qiagen.

Qiagen is a top provider of genomic testing technology and a leader in molecular diagnostics and related instruments.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Diversified Services